,,,""given Repros' need for cash. 6-9 (?)months of additional delay waiting for UF trial data is a lot of additional time with the cash at hand.""
Have to suggest management (and Efficacy) have that one covered.
(assuming no announced partnerships,,,dilution of 1 or 2 million shares , (even 4 million shares if necessary), should cover their $$$ shortage)
jmo